Looks like there`s been an error while trying to load this page.
Our team has been notified but please contact us using the email support widget if the problem persists.
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM P/E Multiple | -12.7x - -14.1x | -13.4x |
| Selected Fwd P/E Multiple | 8.7x - 9.6x | 9.1x |
| Fair Value | €0.53 - €0.59 | €0.56 |
| Upside | 33.4% - 47.5% | 40.5% |
| Benchmarks | - | Full Ticker |
| EssilorLuxottica Société anonyme | - | LSE:0OMK |
| Surgical Innovations Group plc | - | AIM:SUN |
| MyHealthChecked PLC | - | AIM:MHC |
| Creo Medical Group PLC | - | AIM:CREO |
| Abingdon Health Plc | - | AIM:ABDX |
| INSPECS Group plc | - | DB:4GV |
| - | - | - |
| Select Price / LTM EPS Ratio | ||||||||
| Benchmark Companies | ||||||||
| 0OMK | SUN | MHC | CREO | ABDX | 4GV | |||
| LSE:0OMK | AIM:SUN | AIM:MHC | AIM:CREO | AIM:ABDX | DB:4GV | |||
| Historical Net Income Growth | ||||||||
| 5Y CAGR | 17.0% | NM- | NM- | NM- | NM- | NM- | ||
| 3Y CAGR | 17.7% | NM- | NM- | NM- | NM- | NM- | ||
| Latest Twelve Months | 3.1% | -547.9% | -649.7% | 10.4% | -14.8% | -201.5% | ||
| Historical Net Income Profit Margin | ||||||||
| 5 Year Average Margin | 7.4% | -15.8% | -2301.3% | -26082.7% | -206.9% | -2.8% | ||
| Prior Fiscal Year | 9.0% | 2.3% | 6.8% | -98.9% | -85.8% | -3.1% | ||
| Latest Fiscal Year | 8.9% | -4.2% | -1.4% | -70.5% | -20.7% | -0.5% | ||
| Latest Twelve Months | 8.9% | -5.0% | -11.1% | -73.9% | -37.9% | -2.1% | ||
| Current Trading Multiples | ||||||||
| EV / LTM EBITDA | 22.1x | -12.1x | -1.1x | -2.1x | -9.8x | 8.5x | ||
| Price / LTM Sales | 4.2x | 0.4x | 0.8x | 1.5x | 3.3x | 0.2x | ||
| LTM P/E Ratio | 47.1x | -8.1x | -7.0x | -2.0x | -8.7x | -10.4x | ||
| Low | Mid | High | ||||||
| Benchmark LTM P/E Ratio | -8.7x | -7.0x | 47.1x | |||||
| Historical LTM P/E Ratio | -94.4x | -65.6x | -8.2x | |||||
| Selected P/E Multiple | -12.7x | -13.4x | -14.1x | |||||
| (x) LTM Net Income | (4) | (4) | (4) | |||||
| (=) Equity Value | 52 | 55 | 58 | |||||
| (/) Shares Outstanding | 115.3 | 115.3 | 115.3 | |||||
| Implied Value Range | 0.45 | 0.48 | 0.50 | |||||
| FX Rate: GBP/EUR | 0.9 | 0.9 | 0.9 | Market Price | ||||
| Implied Value Range (Trading Cur) | 0.53 | 0.56 | 0.58 | 0.40 | ||||
| Upside / (Downside) | 32.5% | 39.5% | 46.5% | |||||
| Equity Value | |||||||
| Benchmark Companies | |||||||
| (in millions) | 0OMK | SUN | MHC | CREO | ABDX | 4GV | |
| Value of Common Equity | 110,432 | 5 | 7 | 44 | 22 | 39 | |
| (/) Shares Outstanding | 456.7 | 932.8 | 52.0 | 402.5 | 375.9 | 115.3 | |
| Implied Stock Price | 241.80 | 0.01 | 0.14 | 0.11 | 0.06 | 0.34 | |
| FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 0.86 | |
| Implied Stock Price (Trading Cur) | 241.80 | 0.01 | 0.14 | 0.11 | 0.06 | 0.40 | |
| Trading Currency | EUR | GBP | GBP | GBP | GBP | EUR | |
| FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 0.86 | |